Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 391,000 | 117,432 | 45,653 | 18,987 | 226,451 |
| Depreciation Amortization | 6,336 | 4,082 | 2,234 | 835 | 6,579 |
| Income taxes - deferred | -249,879 | N/A | N/A | N/A | N/A |
| Accounts receivable | -22,718 | -17,111 | -8,766 | -7,004 | -472 |
| Accounts payable and accrued liabilities | -5,289 | 5,555 | 3,905 | 1,903 | -1,351 |
| Other Working Capital | -89,756 | -1,847 | 10,672 | -10,879 | 4,155 |
| Other Operating Activity | 80,142 | 50,456 | 30,581 | 16,481 | -77,643 |
| Operating Cash Flow | $109,836 | $158,567 | $84,279 | $20,323 | $157,719 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -692,565 | -534,951 | -330,398 | -156,011 | -505,095 |
| PPE Investments | -4,690 | -685 | -297 | N/A | -523 |
| Purchase Of Investment | N/A | N/A | N/A | 130,800 | N/A |
| Sale Of Investment | 493,529 | 387,779 | 262,190 | N/A | 328,565 |
| Purchase Sale Intangibles | N/A | -98,838 | -98,838 | -98,838 | N/A |
| Other Investing Activity | -98,838 | -98,838 | -98,838 | -98,838 | 146,515 |
| Investing Cash Flow | $-302,564 | $-246,695 | $-167,343 | $-124,049 | $-30,538 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,883 | 27,217 | 17,794 | 1,838 | 6,845 |
| Financing Cash Flow | $49,883 | $27,217 | $17,794 | $1,838 | $6,845 |
| Exchange Rate Effect | 26 | 19 | 19 | -5 | -94 |
| Beginning Cash Position | 328,359 | 328,359 | 328,359 | 328,359 | 194,427 |
| End Cash Position | 185,540 | 267,467 | 263,108 | 226,466 | 328,359 |
| Net Cash Flow | $-142,819 | $-60,892 | $-65,251 | $-101,893 | $133,932 |
| Free Cash Flow | |||||
| Operating Cash Flow | 109,836 | 158,567 | 84,279 | 20,323 | 157,719 |
| Capital Expenditure | -4,690 | -685 | -297 | N/A | -523 |
| Free Cash Flow | 105,146 | 157,882 | 83,982 | 20,323 | 157,196 |